Literature DB >> 34917244

Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917244      PMCID： PMC8667056          DOI： 10.1021/acsmedchemlett.1c00607

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.

Authors:  Pei Teng Lum; Mahendran Sekar; Siew Hua Gan; Srinivasa Reddy Bonam; Mohd Farooq Shaikh
Journal:  ACS Chem Neurosci       Date:  2021-01-21       Impact factor: 4.418

Review 2.  Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

Authors:  Chia-Lung Chuang; Fabio Demontis
Journal:  Ageing Res Rev       Date:  2021-05-09       Impact factor: 11.788

Review 3.  In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease.

Authors:  Harleen Kohli; Pravir Kumar; Rashmi K Ambasta
Journal:  Heliyon       Date:  2021-02-12

Review 4.  Mitophagy in Huntington's disease.

Authors:  I Šonský; P Vodička; K Vodičková Kepková; H Hansíková
Journal:  Neurochem Int       Date:  2021-07-28       Impact factor: 3.921

Review 5.  Irritability in Huntington's Disease.

Authors:  Nicholas E Karagas; Natalia Pessoa Rocha; Erin Furr Stimming
Journal:  J Huntingtons Dis       Date:  2020

Review 6.  Therapeutic Advances for Huntington's Disease.

Authors:  Ashok Kumar; Vijay Kumar; Kritanjali Singh; Sukesh Kumar; You-Sam Kim; Yun-Mi Lee; Jong-Joo Kim
Journal:  Brain Sci       Date:  2020-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.